These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5044666)

  • 21. [The effect of cycloferon administration on the growth of transplantable tumors in rats and mice].
    Zabezhinskiĭ MA; Popovich IG; Shtylik AV; Kovalenko AL; Anisimov VN
    Vopr Onkol; 1998; 44(4):427-31. PubMed ID: 9807206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Enhancement of anti-cancer effect by potential lethal damage repair(PLDR)-inhibitors].
    Akagi K; Sogawa M; Tanaka Y
    Gan No Rinsho; 1983 Oct; 29(13):1613-8. PubMed ID: 6668669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of approaches for augmenting the serologic response to the individually specific methylcholanthrene-induced sarcoma-Meth A: pretreatment with cyclophosphamide is most effective.
    Livingston PO; DeLeo AB; Jones M; Oettgen HF
    J Immunol; 1983 Nov; 131(5):2601-5. PubMed ID: 6631013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of antitumor and antimetastatic activity of pepstatin A in some experimental tumor models.
    Tumminello FM; Leto G; Gebbia N; Rausa L; Bernacki RJ
    J Chemother; 1989 Jul; 1(4 Suppl):1135-8. PubMed ID: 16315374
    [No Abstract]   [Full Text] [Related]  

  • 25. Combined effect of cytostatic drugs and E-N-L-trimethyl lysine in healthy and transplantable tumor bearing mice.
    Szende B; Lapis K; Simon K
    Neoplasma; 1982; 29(4):427-39. PubMed ID: 6813749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor properties of 1,3-oxazine derivatives. I. Derivatives of 5-nitrotetrahydro-1,3-oxazines.
    Mordarski M; Chylińska B; Urbański T
    Arch Immunol Ther Exp (Warsz); 1970; 18(6):679-99. PubMed ID: 5493086
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative studies on the effectiveness of various cytostatics and radiation therapy of experimental tumors in a sample experiment with special regard to telegammatherapy with cobalt60. Survival experiments and cures after the administration of cyclophosphamide ester, triethyleneiminebenzoquinone and radiation separately and in various combinations with Yoshida sarcoma, carcinoma Walker and Jensen sarcoma in albino rats].
    Schneider R
    Strahlentherapie Sonderb; 1965; 61():367-72. PubMed ID: 5827135
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on the antitumor activity of 6-merceptopurine riboside. I.
    Sato K; Nakai Y; Kurita K
    Sci Rep Res Inst Tohoku Univ Med; 1970 Dec; 17(3):92-8. PubMed ID: 5525312
    [No Abstract]   [Full Text] [Related]  

  • 29. Mcl-1 is a novel therapeutic target for human sarcoma: synergistic inhibition of human sarcoma xenotransplants by a combination of mcl-1 antisense oligonucleotides with low-dose cyclophosphamide.
    Thallinger C; Wolschek MF; Maierhofer H; Skvara H; Pehamberger H; Monia BP; Jansen B; Wacheck V; Selzer E
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4185-91. PubMed ID: 15217956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotherapy and chemotherapy of Moloney sarcoma virus-induced tumors in mice.
    Fefer A
    Cancer Res; 1969 Dec; 29(12):2177-83. PubMed ID: 5369675
    [No Abstract]   [Full Text] [Related]  

  • 31. Cyclophosphane 'pulses' in three inbred strains of mice with experimental immune complex nephritis.
    Samoilov DV; Ivanov AA; Gladskich OP; Shilov EM
    Nephron; 1990; 55(3):338. PubMed ID: 2142516
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experimental studies on the combined effect of cyclophosphamide and 5-fluorouracil on sarcoma 180 depending on dosage and timing].
    Osswald H; Satter W
    Arzneimittelforschung; 1970 Jun; 20(6):781-8. PubMed ID: 5468893
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effect of water-salt regimen on the growth of transplantable tumors and the activity of antineoplastic drugs].
    Pashinskiĭ VG
    Vopr Onkol; 1971; 17(3):77-80. PubMed ID: 5563182
    [No Abstract]   [Full Text] [Related]  

  • 34. Combination therapy by using cyclophosphamide and tumor-sensitized lymphocytes: a possible mechanism of action.
    Evans R
    J Immunol; 1983 Jun; 130(6):2511-3. PubMed ID: 6133894
    [No Abstract]   [Full Text] [Related]  

  • 35. [Increase in the concentration of alpha-fetoprotein in the blood of mice following a single dose of cyclophosphane].
    Serova IA; Iunker VM; Kaledin VI
    Biull Eksp Biol Med; 1981 May; 91(5):562-4. PubMed ID: 6167301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of circadian rhythm of cell division on the efficacy of cyclophosphamide on sarcoma induced by methylcholanthrene].
    Focan C; Barbason H; Betz EH
    C R Acad Hebd Seances Acad Sci D; 1973 Mar; 276(13):2105-8. PubMed ID: 4204289
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of sarcolysine and 5-fluorouracil on the growth of transplanted tumors and on the reaction of the surrounding loose connective tissue].
    Iushkov SF; Rozenberg IB
    Farmakol Toksikol; 1971; 34(6):718-22. PubMed ID: 5139797
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on the antitumor activity of 6-mercaptopurine riboside. II.
    Nakai Y; Sato K; Kurita K
    Sci Rep Res Inst Tohoku Univ Med; 1970 Dec; 17(3):99-105. PubMed ID: 5525313
    [No Abstract]   [Full Text] [Related]  

  • 39. Experimental research in the influence of the endocrine status on the antiblastic activity of cytostatics.
    Zimel H
    Neoplasma; 1967; 14(4):345-52. PubMed ID: 6063010
    [No Abstract]   [Full Text] [Related]  

  • 40. Further studies on the tumor inhibitory effects of carbobenzoxy derivatives of amino acids.
    Shohat B; Schlesinger M; Grossowicz N; Lichtenstein N
    Isr J Med Sci; 1972 Jan; 8(1):29-33. PubMed ID: 5067528
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.